Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Unknown authors
Abstract
Fa'ak F, Buni M, Falohun A, et al . Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J Immunother Cancer 2023;11:e006814. doi: 10.1136/jitc-2023-006814 In the original publication, Noha Abdel-Wahab had not been listed as a
Topics & Concepts
Immune systemAdverse effectMedicineInterleukinImmunologyBioinformaticsPharmacologyBiologyCytokineImmunodeficiency and Autoimmune DisordersUrticaria and Related ConditionsCytokine Signaling Pathways and Interactions